Risperidone long-acting injection (RLAI): The 12-week efficacy and tolerability in thai patients with chronic schizophrenia

• Main Authors: Arunpongpaisal S., Srisurapanont M., Kongsakon R., Kitiwattanagul K., Samanwongthai U.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77951895519&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/43339
• Institution: Chiang Mai University

Background: Although oral atypical antipsychotics have improved the outcomes in schizophrenia, the patient medication adherence plays role as the important factor to clinical potential of the drugs. Therefore, the long-acting formulations of antipsychotics have been developed to improve the treatmen...